PubRank
Search
About
The Effects of IABP Prior to Revascularization on Mortality of ACS Patients Complicated With Cardiogenic Shock
Clinical Trial ID NCT03635840
PubWeight™ 0.00
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT03635840
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Intraaortic balloon support for myocardial infarction with cardiogenic shock.
N Engl J Med
2012
9.22
2
Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.
N Engl J Med
1999
6.93
3
Circulatory shock.
N Engl J Med
2013
4.95
4
A tale of coronary artery disease and myocardial infarction.
N Engl J Med
2012
4.53
5
A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?
Eur Heart J
2009
3.06
6
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
J Am Coll Cardiol
2005
2.71
7
Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective.
Circulation
2009
2.60
8
Cardiogenic shock: current concepts and improving outcomes.
Circulation
2008
2.60
9
Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction.
JAMA
2006
2.35
10
The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2.
Am Heart J
2001
2.01
11
Cardiogenic shock complicating acute myocardial infarction; prognostic impact of early and late shock development.
Eur Heart J
2003
1.66
12
Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease.
Circulation
2008
1.47
13
Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline.
Dtsch Arztebl Int
2012
1.06
14
Augmentation of regional coronary blood flow by intra-aortic balloon counterpulsation in patients with unstable angina.
Circulation
1983
0.94
15
Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction.
Am J Cardiol
2010
0.94
16
Intra-aortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction.
Am J Cardiol
1999
0.87
17
Lactate and lactate clearance in acute cardiac care patients.
Eur Heart J Acute Cardiovasc Care
2012
0.85
18
Early revascularization is beneficial across all ages and a wide spectrum of cardiogenic shock severity: A pooled analysis of trials.
Acute Card Care
2011
0.75
19
Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation.
Med Klin Intensivmed Notfmed
2015
0.75
20
Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: A biomarker substudy of the IABP-SHOCK II-trial.
Int J Cardiol
2015
0.75
21
Have we given up on intra-aortic balloon counterpulsation in post-myocardial infarction cardiogenic shock?
Clin Cardiol
2013
0.75
Next 100